These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23163739)

  • 1. Lower urinary tract symptoms in patients with Niigata Minamata disease: a case-control study 50 years after methyl mercury pollution.
    Hara N; Saito H; Takahashi K; Takeda M
    Int J Urol; 2013 Jun; 20(6):610-5. PubMed ID: 23163739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms.
    Chiu AF; Liao CH; Wang CC; Wang JH; Tsai CH; Kuo HC
    Urology; 2012 Feb; 79(2):260-5. PubMed ID: 22137542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey.
    Zumrutbas AE; Bozkurt AI; Tas E; Acar CI; Alkis O; Coban K; Cetinel B; Aybek Z
    Int J Urol; 2014 Oct; 21(10):1027-33. PubMed ID: 24931070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower urinary tract symptoms in men and women without underlying disease causing micturition disorder: a cross-sectional study assessing the natural history of bladder function.
    Araki I; Zakoji H; Komuro M; Furuya Y; Fukasawa M; Takihana Y; Takeda M
    J Urol; 2003 Nov; 170(5):1901-4. PubMed ID: 14532803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects of the Niigata Minamata disease].
    Shimohata T; Hirota K; Takahashi H; Nishizawa M
    Brain Nerve; 2015 Jan; 67(1):31-8. PubMed ID: 25585433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal and postnatal methyl mercury exposure in Niigata, Japan: adult outcomes.
    Saito H; Sekikawa T; Taguchi J; Shozawa T; Kinoshita Y; Matsumura K; Yanagihara K; Nikaido K; Urasaki S; Imaizumi H; Hatano H
    Neurotoxicology; 2020 Dec; 81():364-372. PubMed ID: 35587140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
    Kaplan SA; Roehrborn CG; Rovner ES; Carlsson M; Bavendam T; Guan Z
    JAMA; 2006 Nov; 296(19):2319-28. PubMed ID: 17105794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?
    Bang WJ; Lee JY; Koo KC; Hah YS; Lee DH; Cho KS
    Urology; 2014 Sep; 84(3):670-4. PubMed ID: 25168549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography.
    Pinggera GM; Mitterberger M; Steiner E; Pallwein L; Frauscher F; Aigner F; Bartsch G; Strasser H
    BJU Int; 2008 Aug; 102(4):470-4. PubMed ID: 18476974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years.
    Malmsten UG; Molander U; Peeker R; Irwin DE; Milsom I
    Eur Urol; 2010 Jul; 58(1):149-56. PubMed ID: 20356669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term exposure to methylmercury and neurologic signs in Minamata and neighboring communities.
    Yorifuji T; Tsuda T; Takao S; Harada M
    Epidemiology; 2008 Jan; 19(1):3-9. PubMed ID: 18091411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term exposure to methylmercury and psychiatric symptoms in residents of Minamata, Japan.
    Yorifuji T; Tsuda T; Inoue S; Takao S; Harada M
    Environ Int; 2011 Jul; 37(5):907-13. PubMed ID: 21470684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between obesity and lower urinary tract symptoms: propensity score matching study between healthy controls and obese patients seeking bariatric surgery.
    Kim JH; Sun HY; Park SY; Soh MJ; Kim YJ; Song YS
    Surg Obes Relat Dis; 2016; 12(8):1585-1593. PubMed ID: 27425838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital Minamata disease: a description of two cases in Niigata.
    Saito H
    Neurotoxicology; 2020 Dec; 81():360-363. PubMed ID: 33741117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of supervoiders who suffer from lower urinary tract symptoms: a propensity score-matching study.
    Lee JY; Hah YS; Lee DH; Bang WJ; Ham WS; Lee SW; Cho KS
    World J Urol; 2013 Dec; 31(6):1463-8. PubMed ID: 23624717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
    Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey on prevalence of lower urinary tract symptoms in an Asian population.
    Yee CH; Chan CK; Teoh JYC; Chiu PKF; Wong JHM; Chan ESY; Hou SSM; Ng CF
    Hong Kong Med J; 2019 Feb; 25(1):13-20. PubMed ID: 30655460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.